Metraipolis › archive › dc_992d66f158de
Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies… — Europe PMC PMID:42412773
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42412773
- DOI
- 10.1371/journal.pone.0353258
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T10:43:04.368Z
- SHA-256 of the archived text
aba174544629a575370a4c0c3962cdf384057810b95db5ba6bf1b2fa35d940fc- Stable URL of this page
https://metraipolis.com/documento/dc_992d66f158de
How to cite
Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies… — Europe PMC PMID:42412773 — Europe PMC (en), https://europepmc.org/article/MED/42412773 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_992d66f158de (Metraipolis archive dc_992d66f158de, sha256 aba174544629a575370a4c0c3962cdf384057810b95db5ba6bf1b2fa35d940fc)
BibTeX
@misc{dc992d66f158de,
title = {Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies… — Europe PMC PMID:42412773},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42412773},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_992d66f158de; sha256 aba174544629a575370a4c0c3962cdf384057810b95db5ba6bf1b2fa35d940fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42412773. Agents can read the archived copy with the MCP tool read_document.